Dialysis Market size is projected to surpass USD 155 billion by the end of 2033, growing at a CAGR of 5% during the forecast period, i.e., 2023-2033. In the year 2022, the industry size of dialysis was USD 110 billion. An increase in the prevalence of chronic kidney diseases, and a rise in the approval of new products are anticipated to boost the global dialysis market size during the forecast period. Moreover, there are an increasing number of patients suffering from chronic kidney disease is further projected to boost the market’s growth. As per the Centers for Disease Control and Prevention (CDC) greater than 1 in 7 adults, or 15% of the U.S adults, are estimated to have chronic kidney disease, i.e., about 37 million people in 2021.
Increasing healthcare infrastructure and growing research and development activities are estimated to drive the growth of the global dialysis market in the coming years. The Centers for Medicare & Medicaid Services (CMS) declared the End-Stage Renal Disease (ESRD) Treatment Choices (ETC) Model to enhance and provide quality care by reducing the chronic kidney disease expenditure for patients of Medicare. In addition, it is estimated that the ETC model will save USD 23 million in five and a half years. Moreover, the growing number of awareness campaigns regarding the treatment efficacy of dialysis is anticipated to fuel the potential for market expansion over the forecast period.
Growth Drivers
Increasing Cases of Chronic Kidney Disease - Chronic kidney diseases or chronic kidney failure is the damage to the kidney to function normally. The damaged kidneys cannot filter blood to remove toxins. This will eventually lead to multi-organ damage, leading to hypertension, heart failure, a heart stroke, or death. Dialysis is one of the best options for treating chronic kidney disease, along with medical care. Moreover, unhealthy eating habits and the practice sedentary lifestyle make people more prone to kidney disease and are estimated to boost the market growth during the forecast period. As per the estimations, about 11% of the world’s population are suffering from chronic kidney disease in 2022.
Growing Prevalence of Diabetes Among the People - Diabetes affects every tissue, organ, and cell of the body, that increases the demand for dialysis among them. Hence, it is anticipated to surge the global dialysis market over the forecast period. As per the CDC, about 34.2 million people, or 10.5% of the population including all age groups, suffered from diabetes in the U.S in 2018.
Increase in Renal Complications of Patients during COVID - As per the estimations, about 25% of global patients hospitalized with COVID-19 developed kidney injuries, and over 45% of patients with kidney injuries in the ICU (intensive care unit) needed dialysis
Rise in the Geriatric Population Across the World - There are higher chances among the aged population to be affected by the diseases, as the immunity gets weaken with age, and it is projected to drive the global dialysis market. As per the estimations, the number of old people across the world will double by 2050 and reach 2 billion up from 1.5 billion in 2030.
Challenges
Rise in Kidney Transplantation - In the last decade, the number of live donor kidney transplants performed in the US and Canada has doubled and now represents just over 40% of all donor kidneys. Among deceased donor kidneys, the largest percentage increases were seen in expanded criteria donors and kidneys donated after cardiac death.
|
Base Year |
2022 |
|
Forecast Year |
2023-2033 |
|
CAGR |
~5% |
|
Base Year Market Size (2022) |
~ USD 110 Billion |
|
Forecast Year Market Size (2033) |
~ USD 155 Billion |
|
Regional Scope |
|
Type (Hemodialysis, Peritoneal Dialysis)
The global dialysis market is segmented and analyzed for demand and supply by type into hemodialysis, and peritoneal dialysis. Out of these, the hemodialysis segment is anticipated to hold the largest market size by the end of 2033 owing to the efficiency of dialysis to remove toxic materials and the rise of homecare adoption in end-stage renal disease and growing hypertension cases. As per the Centers for Disease Control and Prevention, over 670,000 deaths occurred owing to hypertension in the U.S in 2020. Hemodialysis is a process where blood is cleaned using a dialysis machine and a specific filter called an artificial kidney, or a dialyzer. The doctor must gain access to blood vessels in order to enter blood into the dialyzer. Minor surgery is used to accomplish this, typically on the arm. Hemodialysis can be carried out at home, in a hospital, or in a separate dialysis facility. A patient's doctor will pick the ideal location depending on the patient's medical needs and preferences.
End-user (In-Center, Home Dialysis)
The global dialysis market is also segmented and analyzed for demand and supply by end-user into in-center, and home dialysis. Amongst these two segments, the in-center segment is expected to garner a significant share. Patients needing dialysis often visit centers for treatment, and it is easier and convenient for them to have the treatment directly from the same hospital or center premises, where it was diagnosed. When a person receives their dialysis treatments in-center, they do it at a dialysis facility. When the kidneys are unable to do this task, dialysis is a procedure that removes wastes and excess fluid from the blood.
Our in-depth analysis of the global market includes the following segments:
|
By Type |
|
|
By Product and Service |
|
|
By End-User |
|
North American Market Forecast
The North America market, amongst the market in all the other regions, is projected to hold the largest market share by the end of 2033 on account of rising healthcare expenditure, and growing disposable income, and rising demand for the development of new products. The national health expenditure of the U.S. in 2020, rose by 9.7% and reached USD 4.1 trillion, or USD 12,350 for every person, as per the CMS. Further, the presence of a strong healthcare network in the region, along with the availability of supportive policies by the regulatory bodies that promote the market players to opt for investing into more research works to bring up more feasible solutions so as to develop efficient treatment options, are also anticipated to contribute to the market growth in the region.
Medtronic plc and DaVita Inc. declared to form a company named “NewCo” to improve the patient experience and enhance the development of various therapies for kidney failure patients.
Diaverum AB announced the acquisition of booknowmed.com, a holiday dialysis product and the leading global booking engine that shows users 400 dialysis clinics across 54 countries to book their dialysis treatment
Author Credits: Radhika Gupta, Shivam Bhutani
FREE Sample Copy includes market overview, growth trends, statistical charts & tables, forecast estimates, and much more.
Have questions before ordering this report?